Results 261 to 270 of about 32,714,285 (374)

A rapid evaluation of the UK Health Security Agency's New Variant Assessment Platform global genomic surveillance programme. [PDF]

open access: yesPLOS Glob Public Health
Sanderson K   +7 more
europepmc   +1 more source

Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

open access: yesEuropean journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology, 2008
S. Nagueh   +9 more
semanticscholar   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

Promoting low carbon behaviours through personalised information? Long-term evaluation of a carbon calculator interview

open access: hybrid, 2018
Milena Büchs   +7 more
openalex   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Earlier Orthopaedic Surgeon Evaluation of Workers' Compensation Associated With Higher Return to Full Duty After Shoulder Arthroscopy. [PDF]

open access: yesJ Am Acad Orthop Surg Glob Res Rev
Massey PA   +5 more
europepmc   +1 more source

Evaluating Evaluations

open access: yesJournal of College Orientation, Transition, and Retention, 2019
openaire   +3 more sources

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy